Pharmaceutical and biotech product development consultancy Boyds has opened its US office in the Philadelphia area and welcomed Katy Rudnick as vice president and head of US Regulatory Affairs to head up the newly established US company.   Since Boyds was established in 2005, the company has worked with US companies seeking to develop and gain approval for their medicines in Europe and further afield. Boyds’ global reputation for its work in advanced therapies has led to a steady increase in the...